Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s share price shot up 1.8% during trading on Wednesday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares changed hands during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8 %
The company has a debt-to-equity ratio of 0.52, a quick ratio of 9.41 and a current ratio of 9.74. The stock’s fifty day simple moving average is C$0.58 and its two-hundred day simple moving average is C$0.58. The company has a market capitalization of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- How to Effectively Use the MarketBeat Ratings Screener
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- ESG Stocks, What Investors Should Know
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What is Put Option Volume?
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
